It has been reported that small molecules play a critical role in maintaining the undifferentiated state and inducing the differentiation of ES/iPS cells.
We offer small molecules manufactured in compliance with ICH-Q7 (GMP for APIs). These products are produced under GMP and are designed for use as raw materials in the commercial production of regenerative medicines. They are well-suited for use in the manufacturing processes of regenerative medicines utilizing human ES/iPS cells and other stem cells.